Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01)

NCT06860477 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocellular Carcinoma

Interventions

DRUG: Tislelizumab
DRUG: Lenvatinib
PROCEDURE: cryoablation
DRUG: FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin)

Sponsor

Fudan University